New Results
The MKRN1-BRAF exon4-exon9 fusion is a targetable oncogenic driver
View ORCID ProfileMegan A. Girtman, Craig S. Richmond, View ORCID ProfileParaic A. Kenny
doi: https://doi.org/10.1101/2021.07.22.453427
Megan A. Girtman
1Kabara Cancer Research Institute, Gundersen Medical Foundation, 1300 Badger Street, La Crosse, WI 54601
Craig S. Richmond
1Kabara Cancer Research Institute, Gundersen Medical Foundation, 1300 Badger Street, La Crosse, WI 54601
Paraic A. Kenny
1Kabara Cancer Research Institute, Gundersen Medical Foundation, 1300 Badger Street, La Crosse, WI 54601
2University of Wisconsin School of Medicine and Public Health, Madison, WI
Article usage
Posted July 23, 2021.
The MKRN1-BRAF exon4-exon9 fusion is a targetable oncogenic driver
Megan A. Girtman, Craig S. Richmond, Paraic A. Kenny
bioRxiv 2021.07.22.453427; doi: https://doi.org/10.1101/2021.07.22.453427
Subject Area
Subject Areas
- Biochemistry (11736)
- Bioengineering (8746)
- Bioinformatics (29186)
- Biophysics (14964)
- Cancer Biology (12084)
- Cell Biology (17401)
- Clinical Trials (138)
- Developmental Biology (9418)
- Ecology (14176)
- Epidemiology (2067)
- Evolutionary Biology (18299)
- Genetics (12235)
- Genomics (16793)
- Immunology (11863)
- Microbiology (28066)
- Molecular Biology (11580)
- Neuroscience (60925)
- Paleontology (451)
- Pathology (1870)
- Pharmacology and Toxicology (3238)
- Physiology (4956)
- Plant Biology (10422)
- Synthetic Biology (2883)
- Systems Biology (7338)
- Zoology (1650)